Skip to content

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

A Prospective Registry for Collecting Standardized, Routine Care Data to Characterize Patients, Treatment Patterns, Safety and Treatment Effectiveness in Adult Oncology Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06877884
Enrollment
20000
Registered
2025-03-14
Start date
2022-08-01
Completion date
2099-01-31
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.

Detailed description

This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.

Interventions

None listed

Sponsors

N-Power Medicine
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
Yes

Inclusion criteria

Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent

Exclusion criteria

Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative

Design outcomes

Primary

MeasureTime frameDescription
Treatment Effectiveness - Time to treatment discontinuationThis is an open-ended registry where data will be collected, analysed and presented regularly over time.Effectiveness outcomes of treatments used in routine clinical care (such as for instance time to treatment discontinuation ) will be captured

Countries

United States

Contacts

Primary ContactChrister Svedman, MD
support@npowermedicine.com833-467-6734
Backup ContactLouise Polychronopoulos, PhD
support@npowermedicine.com833-467-6734

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026